已发表论文

补阳益胃汤调节肠道菌群治疗胃癌的研究进展

 

Authors Li Y, Wang M , Zhao H

Received 15 September 2024

Accepted for publication 26 November 2024

Published 23 December 2024 Volume 2024:16 Pages 1863—1869

DOI https://doi.org/10.2147/CMAR.S496404

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Seema Singh

Yu Li,1 Manya Wang,2 Huixie Zhao3 

1Oncology Department, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, People’s Republic of China; 2Department of Traditional Chinese Medicine, Shanghai Pudong New Area Nanhui Xincheng Community Health Service Center, Pudong New Area, Shanghai, People’s Republic of China; 3Department of Traditional Chinese Medicine, Shijiazhuang TCM Hospital, Shijiazhuang, People’s Republic of China

Correspondence: Manya Wang, Email wangmanya@126.com

Abstract: Intestinal flora is a complex micro-ecosystem in human body, which is called the second genome of human body. Intestinal flora imbalance plays an important role in the occurrence and development of gastric cancer through circulation, metabolism and immunity. Gastric cancer is associated with dysbacteriosis. Traditional Chinese medicine (TCM) compounds in Buyang Yiwei Decoction can reduce the clinical signs and symptoms of gastric cancer by regulating intestinal microbiota, alleviate the adverse reactions of gastric cancer after radiotherapy and chemotherapy, and improve the quality of life of patients. This article reviews whether Buyang Yiwei Decoction can reduce the risk of gastric cancer or play a therapeutic role in gastric cancer by improving the intestinal microbiota.

Keywords: traditional Chinese medicine, gastric cancer, intestinal microbiota, treatment